Brief: Oasmia Pharmaceutical And Elevar Sign Partnership Deal

Vivesto AB

25/03/2020 06:07

March 25 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * OASMIA PHARMACEUTICAL AB AND US BASED ELEVAR THERAPEUTICS
INC.
HAVE SIGNED A GLOBAL STRATEGIC PARTNERSHIP DEAL REGARDING
COMMERCIALIZATION OF OASMIA'S ANTICANCER PRODUCT APEALEA®
    * ELEVAR WILL ALSO PAY OASMIA DOUBLE-DIGIT ROYALTIES ON
SALES OF
APEALEA®

Source text for Eikon:  ID:nNDL1jGD8V 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))